FIELD: chemistry.
SUBSTANCE: invention relates to derivatives of a glycopeptide antibiotic of general formula (I).
EFFECT: derivatives have antimicrobial activity towards vancomycin-resistant bacteria.
22 cl, 129 tbl, 13 ex
Title | Year | Author | Number |
---|---|---|---|
TRPV1 ANTAGONISTS AND USE THEREOF | 2008 |
|
RU2452733C2 |
COMBINED THERAPY INCLUDING SGLT INHIBITORS AND DPP4 INHIBITORS | 2009 |
|
RU2481106C2 |
COMBINATIONS OF ACTIVATOR (ACTIVATORS) OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR), AND INHIBITOR (INHIBITORS) OF STEROL ABSORPTION AND TREATMENT OF VASCULAR DISEASES | 2008 |
|
RU2483724C2 |
NEUROACTIVE COMPOUNDS AND THEIR APPLICATION METHODS | 2015 |
|
RU2764702C2 |
METHOD FOR SYNTHESIS OF SULPHAMATE-CARBOXYLATE DERIVATIVES | 2006 |
|
RU2403238C2 |
DERIVATIVES OF GLYCOPEPTIDE OR THEIR SALTS, METHOD OF SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2145609C1 |
N-HYDROXYLSULPHONAMIDE DERIVATIVES AS NOVEL PHYSIOLOGICALLY USEFUL NITROXYL DONORS | 2008 |
|
RU2485097C2 |
MODIFIED NUCLEOTIDE LINKERS | 2015 |
|
RU2699993C2 |
ENPP1 INHIBITORS AND METHODS OF MODULATING THE IMMUNE RESPONSE | 2018 |
|
RU2800798C2 |
V1A-RECEPTORS AGONISTS | 2013 |
|
RU2634617C2 |
Authors
Dates
2011-07-20—Published
2005-11-24—Filed